Metastatic esophageal carcinoma masquerading as inflammatory breast carcinoma

International Journal of Dermatology

Volumn 46, Issue 3, 2007, Pages 303-305

  Nebesio, Christy L ^a   Goulet Jr , Robert J ^a   Helft, Paul R ^a   Billings, Steven D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR CDX2;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; PUNCH BIOPSY; SYMPTOMATOLOGY;

ADENOCARCINOMA; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED;

EID: 33847779127     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.03113.x     Document Type: Article

References (25)

1. Cristofanilli M, Buzdar AU, Hortobagyi GN. Update on the management of inflammatory breast cancer. Oncologist 2003; 8: 141-148.
2. Haagensen C. Disease of the Breast, 2nd edn. Philadelphia, PA: Saunders, 1971.
3. Giordano SH, Hortobagyi GN. Inflammatory breast cancer: Clinical progress and the main problems that must be addressed. Breast Cancer Res 2003; 5: 284-288.
4. Gradishar WJ. Inflammatory breast cancer: The evolution of multimodality treatment strategies. Semin Surg Oncol 1996; 12: 352-363.
5. Lopez MJ, Porter KA. Inflammatory breast cancer. Surg Clin North Am 1996; 76: 411-429.
6. Oraedu CO, Pinnapureddy P, Alrawi S, et al. Congestive heart failure mimicking inflammatory breast carcinoma: A case report and review of the literature. Breast J 2001; 7: 117-119.
7. Muller JW, Koehler PR. Cardiac failure simulating inflammatory cancer of the breast. ROFO Fortschr Geb Rontgenstr Nuklearmed 1984; 140: 441-444.
8. Povoski SP, Spigos DG, Marsh WL. An unusual case of cat-scratch disease from Bartonella quintana mimicking inflammatory breast cancer in a 50-year-old woman. Breast J 2003; 9: 497-500.
9. Chambler AF, Drew PJ, Hill AD, et al. Inflammatory breast carcinoma. Surg Oncol 1995; 4: 245-254.
10. Chang JT, Katzka DA. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma. Arch Intern Med 2004; 164: 1482-1488.
11. Wei JT, Shaheen N. The changing epidemiology of esophageal adenocarcinoma. Semin Gastrointest Dis 2003; 14: 112-127.
12. Smith KJ, Williams J, Skelton H. Metastatic adenocarcinoma of the esophagus to the skin: New patterns of tumor recurrence and alternate treatments for palliation. J Cutan Pathol 2001; 28: 425-431.
13. Cavazzini G, Colpani F, Cantore M, et al. Breast metastasis from gastric signet ring cell carcinoma, mimicking inflammatory carcinoma. A case report. Tumori 1993; 79: 450-453.
14. Briest S, Horn LC, Haupt R, et al. Metastasizing signet ring cell carcinoma of the stomach mimicking bilateral inflammatory breast cancer. Gynecol Oncol 1999; 74: 491-494.
15. Nance FC, MacVaugh H 3rd, Fitts WT Jr. Metastatic tumor to the breast simulating bilateral primary inflammatory carcinoma. Am J Surg 1966; 112: 932-935.
16. Whitaker-Worth DL, Carlone V, Susser WS, et al. Dermatologic diseases of the breast and nipple. J Am Acad Dermatol 2000; 43: 733-751.
17. Krishnan EU, Phillips AK, Randell A, et al. Bilateral metastatic inflammatory carcinoma in the breast from primary ovarian cancer. Obstet Gynecol 1980; 55: 94S-96S.
18. Ward R, Conner G, Delprado W, et al. Metastatic adenocarcinoma of the cervix presenting as an inflammatory breast lesion. Gynecol Oncol 1989; 35: 399-405.
19. Ormsby AH, Goldblum JR, Rice TW, et al. The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma. Histopathology 2001; 38: 307-311.
20. Silberg DG, Swain GP, Suh ER, et al. Cdx1 and cdx2 expression during intestinal development. Gastroenterology 2000; 119: 961-971.
21. Suh E, Chen L, Taylor J, et al. A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol 1994; 14: 7340-7351.
22. Phillips RW, Frierson HF Jr, Moskaluk CA. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol 2003; 27: 1442-1447.
23. Werling RW, Yaziji H, Bacchi CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: An immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol 2003; 27: 303-310.
24. Li MK, Folpe AL. CDX-2, a new marker for adenocarcinoma of gastrointestinal origin. Adv Anat Pathol 2004; 11: 101-105.
25. Mazziotta RM, Borczuk AC, Powell CA, et al. CDX2 immunostaining as a gastrointestinal marker: Expression in lung carcinomas is a potential pitfall. Appl Immunohistochem Mol Morph 2005; 13: 55-60.